Ultragenyx Pharmaceutical Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 05/09/2025 | 10.00 M | $361.96 M | -0.39% | 10.38% |
| BLACKROCK, INC. | 05/02/2025 | 6.16 M | $222.99 M | -5.79% | 6.40% |
| SANDS CAPITAL MANAGEMENT, LLC | 05/14/2025 | 4.16 M | $150.76 M | -3.13% | 4.32% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 3.22 M | $116.56 M | 28.12% | 3.34% |
| STATE STREET CORP | 05/15/2025 | 2.62 M | $94.82 M | -3.82% | 2.72% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 2.45 M | $88.70 M | -0.33% | 2.54% |
| CLEARBRIDGE INVESTMENTS, LLC | 05/13/2025 | 2.26 M | $81.82 M | -2.69% | 2.35% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 2.15 M | $77.82 M | 81.64% | 2.23% |
| FEDERATED HERMES, INC. | 05/08/2025 | 2.06 M | $74.42 M | 0.26% | 2.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 2.02 M | $73.31 M | 75.84% | 2.10% |
| RTW INVESTMENTS, LP | 05/15/2025 | 1.71 M | $61.83 M | -13.24% | 1.77% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 1.70 M | $61.61 M | 0.50% | 1.77% |
| ALKEON CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.69 M | $61.04 M | -0.06% | 1.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.65 M | $59.64 M | 5.36% | 1.71% |
| BAKER BROS. ADVISORS LP | 05/15/2025 | 1.58 M | $57.07 M | 0.00% | 1.64% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2025 | 1.50 M | $54.15 M | 3.86% | 1.55% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 1.41 M | $51.96 M | 20.07% | 1.46% |
| DEEP TRACK CAPITAL, LP | 05/15/2025 | 1.35 M | $48.88 M | 106.58% | 1.40% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 1.25 M | $45.17 M | -23.38% | 1.30% |
| INVESCO LTD. | 05/12/2025 | 1.21 M | $43.93 M | -28.62% | 1.26% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2025 | 1.15 M | $41.66 M | 20.08% | 1.19% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 976.05 K | $35.34 M | -17.48% | 1.01% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 937.20 K | $33.94 M | 2.59% | 0.97% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 852.66 K | $30.87 M | 2.80% | 0.89% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 830.00 K | $30.05 M | 0.00% | 0.86% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 824.42 K | $29.85 M | 10.30% | 0.86% |
| CANDRIAM S.C.A. | 05/14/2025 | 728.02 K | $26.36 M | 7.97% | 0.76% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 712.39 K | $25.80 M | 2.17% | 0.74% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 696.16 K | $25.21 M | -5.79% | 0.72% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 658.72 K | $23.85 M | 0.00% | 0.68% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 651.38 K | $23.59 M | 100.00% | 0.68% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 633.15 K | $22.93 M | 2.96% | 0.66% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 05/15/2025 | 632.03 K | $22.89 M | -17.23% | 0.66% |
| EAGLE HEALTH INVESTMENTS LP | 05/12/2025 | 627.60 K | $22.73 M | 0.00% | 0.65% |
| MORGAN STANLEY | 05/15/2025 | 626.40 K | $22.68 M | 4.72% | 0.65% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 600.45 K | $21.74 M | 40.50% | 0.62% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 593.12 K | $21.48 M | -3.34% | 0.62% |
| NORTHERN TRUST CORP | 05/13/2025 | 568.39 K | $20.58 M | 7.45% | 0.59% |
| LOOMIS SAYLES & CO L P | 05/14/2025 | 561.48 K | $20.33 M | 100.00% | 0.58% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 556.42 K | $20.15 M | 94.50% | 0.58% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 527.98 K | $19.12 M | 35.90% | 0.55% |
| FRED ALGER MANAGEMENT, LLC | 05/16/2025 | 524.64 K | $19.00 M | 12.52% | 0.54% |
| 05/12/2025 | 518.54 K | $18.78 M | 100.00% | 0.54% | |
| EMERALD ADVISERS, LLC | 05/01/2025 | 516.23 K | $18.69 M | -0.41% | 0.54% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/05/2025 | 502.21 K | $18.19 M | -1.44% | 0.52% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 05/02/2025 | 502.02 K | $18.18 M | 0.26% | 0.52% |
| VESTAL POINT CAPITAL, LP | 05/15/2025 | 500.00 K | $18.11 M | -66.67% | 0.52% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 480.27 K | $17.39 M | -13.26% | 0.50% |
| ABRDN PLC | 05/13/2025 | 478.90 K | $17.34 M | 51.01% | 0.50% |
| UBS GROUP AG | 05/13/2025 | 469.48 K | $17.00 M | 44.17% | 0.49% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ultragenyx Pharmaceutical Inc. institutional Ownership - FAQ's
During the previous two years, 404 institutional investors and hedge funds held shares of Ultragenyx Pharmaceutical Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 10 M
BlackRock, Inc.: 6.16 M
SANDS CAPITAL MANAGEMENT, LLC: 4.16 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.22 M
STATE STREET CORP: 2.62 M
WELLINGTON MANAGEMENT GROUP LLP: 2.45 M
90.46% of Ultragenyx Pharmaceutical Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 100.88 M shares in the last 24 months. This purchase volume represents approximately $4.03 B in transactions.